TheProfitWatch

PTGX - Protagonist Therapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
75.61 2.11 (2.79%) --- --- --- 0.0 (0.0%) 2.43 (3.23%) 0.0 (0.0%) -1.33 (-1.73%)

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.55
Diluted EPS:
-0.55
Basic P/E:
-141.3091
Diluted P/E:
-141.3091
RSI(14) 1m:
73.08
VWAP:
77.67
RVol:
0.5399

Events

Period Kind Movement Occurred At

Related News